No black box warning on record for Fosamprenavir Calcium

As of the latest FDA labeling reviewed, Fosamprenavir Calcium (FOSAMPRENAVIR CALCIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Fosamprenavir Calcium medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • The concomitant use of fosamprenavir with ritonavir and certain other drugs may result in known or potentially significant drug interactions. Consult the full prescribing information prior to and during treatment for potential drug interactions. ( 5.1 , 7.3 ) • Fosamprenavir should be discontinued for severe skin reactions, including Stevens-Johnson syndrome. ( 5.2 ) •

No black box warning on record for Fosamprenavir Calcium

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • The concomitant use of fosamprenavir with ritonavir and certain other drugs may result in known or potentially significant drug interactions. Consult the full prescribing information prior to and during treatment for potential drug interactions. ( 5.1 , 7.3 ) • Fosamprenavir should be discontinued for severe skin reactions, including Stevens-Johnson syndrome. ( 5.2 ) •

Fosamprenavir Calcium Black Box Warning

No black box warning on record for Fosamprenavir Calcium

Other warnings & precautions

Fosamprenavir Calcium Black Box Warning

No black box warning on record for Fosamprenavir Calcium

Other warnings & precautions